Jump to ContentJump to Main Navigation
Show Summary Details
More options …

Open Medicine

formerly Central European Journal of Medicine

Editor-in-Chief: Darzynkiewicz, Zbigniew


IMPACT FACTOR 2018: 1.221

CiteScore 2018: 1.01

SCImago Journal Rank (SJR) 2018: 0.329
Source Normalized Impact per Paper (SNIP) 2018: 0.479

ICV 2017: 152.94

Open Access
Online
ISSN
2391-5463
See all formats and pricing
More options …
Volume 7, Issue 2

Issues

Volume 10 (2015)

Safety and efficacy of exercise testing with atropine in patients with recent uncomplicated ST elevation acute myocardial infarction

Filippo Sarullo / Luigi Americo / Salvatore Milia / Ignazio Brusca / Natale Faraone / Antonino Franco / Salvatore Giambanco / Marco Franco / Vittorio Panno / Salvatore Paterna / Pietro Pasquale
Published Online: 2012-02-03 | DOI: https://doi.org/10.2478/s11536-012-0001-4
  • [1] Gibbons RJ, Balady GJ, Timothy Bricker J, Chaitman BR, Fletcher GF, Froelicher VF et al. ACC/AHA 2002 Guideline Update for Exercise Testing: Summary Article. A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Update the 1997 Exercise Testing Guidelines), Circulation 2002; 106; 1883–1892 http://dx.doi.org/10.1161/01.CIR.0000034670.06526.15CrossrefGoogle Scholar

  • [2] Primeau M. Taillefer R, Essiambre R, Lambert R, Honos G. Technetium 99m Sestamibi myocardial perfusion imaging: comparison between treadmill, dipyridamole and trans-oesophageal atrial pacing “stress” tests in normal subjects, Eur J Nucl Med 1991; 18: 247–251 http://dx.doi.org/10.1007/BF00186648CrossrefGoogle Scholar

  • [3] Brown KA, Rowen M. Impact of antianginal medications, peak heart rate and stress level on the prognostic value of a normal exercise myocardial perfusion imaging study, J Nucl Med 1993; 34: 1467–1471 Google Scholar

  • [4] Verzijlbergen JF, Vermeersch PHMJ, Laarman G, Ascoop CAPL. Inadequate exercise leads to suboptimal imaging. Thallium-201 myocardial perfusion imaging after dipyridamole combined with low-level exercise unmasks ischemia in symptomatic patients with non diagnostic thallium-201 scan who exercise submaximally, J Nucl Med 1991; 32: 2071–2078 Google Scholar

  • [5] McLaughlin PR, Martin RP, Doherty P et al. Reproducibility of thallium-201 myocardial imaging, Circulation 1977; 55: 497–503 Google Scholar

  • [6] Manganelli F, Spadafora M, Varrella P et al. Addition of atropine to submaximal exercise stress testing in patients evaluated for suspected ischemia with SPECT imaging: a randomized placebo-controlled trial, Eur J Nucl Med Mol Imaging 2011; 38: 245–251 http://dx.doi.org/10.1007/s00259-010-1641-8CrossrefGoogle Scholar

  • [7] Gibbons RJ, Balady GJ, Beasley JW et al. ACC/AHA guidelines for exercise testing, J Am Coll Cardiol 1997; 30: 260–3111 http://dx.doi.org/10.1016/S0735-1097(97)00150-2CrossrefGoogle Scholar

  • [8] Iskandrian AS, Heo J, Kong B, Lyons E. The effect of exercise level on the ability of thallium-201 tomographic imaging in detecting coronary artery disease: analysis of 461 patients, J Am Coll Cardiol 1989; 14: 1477–1486 http://dx.doi.org/10.1016/0735-1097(89)90385-9CrossrefGoogle Scholar

  • [9] Gauri AJ, Raxwal VK, Roux L et al. Effects of chronotropic incompetence and beta-blocker use on the exercise treadmill test in men, Am Heart J 2001; 142: 136–141 http://dx.doi.org/10.1067/mhj.2001.115788CrossrefGoogle Scholar

  • [10] White MP. Pharmacologic stress testing: understanding the options, J Nucl Cardiol 1999; 6: 672–675 hyperactivity?), Circulation 1996; 93: 1485–1487 CrossrefGoogle Scholar

  • [11] Sarullo FM, Schicchi R, Schirò M et al. Comparative evaluation of dobutamine-atropine stress echocardiography with exercise testing for detection of coronary artery disease [in Italian], G Ital Cardiol 1996; 26: 1279–1290 Google Scholar

  • [12] McNeill AJ, Fioretti PM, el-Said SM et al. Enhanced sensitivity for detection of coronary artery disease by addition of atropine to dobutamine stress echocardiography, Am J Cardiol 1992; 70: 41–46 http://dx.doi.org/10.1016/0002-9149(92)91387-JCrossrefWeb of ScienceGoogle Scholar

  • [13] Secknus MA, Marwick TH. Evolution of dobutamine echocardiography protocols and indications: safety and side effects in 3011 studies over 5 years, J Am Coll Cardiol 1997; 29: 1234–1240 http://dx.doi.org/10.1016/S0735-1097(97)00039-9Google Scholar

  • [14] Geleijnse ML, Elhendy A, van Domburg RT et al. Cardiac imaging for risk stratification with dobutamine -atropine stress testing in patients with chest pain: echocardiography, perfusion scintigraphy, or both?, Circulation 1997; 96: 137–147 CrossrefGoogle Scholar

  • [15] Elhendy A, Valkema R, van Domburg RT et al. Safety of dobutamine-atropine stress myocardial perfusion scintigraphy, J Nucl Med 1998; 39: 1662–1666 PubMedGoogle Scholar

  • [16] Elhendy A, van Domburg RT, Bax JJ et al. The functional significance of chronotropic incompetence during dobutamine stress test, Heart 1999; 81: 398–403 CrossrefGoogle Scholar

  • [17] Geleijnse ML, Elhendy A, Fioretti PM, Roelandt JRTC. Dobutamine stress myocardial perfusion imaging, Am Coll Cardiol 2000; 36: 2017–2027 http://dx.doi.org/10.1016/S0735-1097(00)01012-3CrossrefGoogle Scholar

  • [18] Elhendy A, van Domburg RT, Bax JJ et al. Safety, hemodynamic profile, and feasibility of dobutamine stress technetium myocardial perfusion single- photon emission CT imaging for evaluation of coronary artery disease in the elderly, Chest 2000; 117: 649–656 http://dx.doi.org/10.1378/chest.117.3.649CrossrefGoogle Scholar

  • [19] Ellestad MH, Wan MK. Predictive implications of stress testing: follow-up of 2700 subjects after maximum treadmill stress testing, Circulation 1975; 51: 363–369 Google Scholar

  • [20] Myers J, Prakash M, Froelicher V. Do D, Partington S, Atwood JE. Exercise capacity and mortality among men referred for exercise testing, N Engl J Med 2002; 3546: 793–801 http://dx.doi.org/10.1056/NEJMoa011858CrossrefGoogle Scholar

  • [21] Ledenheim ML, Pollock BH, Rozanshi A et al. Extent and severity of myocardial hypoperfusion as predictors of prognosis in patients with suspected coronary artery disease, J Am Coll Cardiol 1986; 7: 464–471 http://dx.doi.org/10.1016/S0735-1097(86)80454-5CrossrefGoogle Scholar

  • [22] Hachamovitch R, Berman DS, Kiat H et al. Exercise myocardial perfusion SPECT in patients without known coronary artery disease. Incremental prognostic value and use in risk stratification, Circulation 1996; 93: 905–914 CrossrefGoogle Scholar

  • [23] Schinkel AF, Elhendy A, van Domburg RT. Prognostic value of dobutamine-atropine stress (99m) Tc-tetrofosmin myocardial perfusion SPECT in patients with known or suspected coronary artery disease, J Nucl Med 2002; 43: 767–772 Google Scholar

  • [24] Tsutsui JM, Osorio AFF, Lario FC et al. Comparison of safety and efficacy of the early injection of atropine during dobutamine stress echocardiography with the conventional protocol, Am J Cardiol 2004; 94: 1367–1372 http://dx.doi.org/10.1016/j.amjcard.2004.07.141CrossrefGoogle Scholar

  • [25] Caner B, Karanfil A, Uysal U. Effect of an additional atropine injection during dobutamine infusion for myocardial SPECT, Nucl Med Commun 1997; 18: 567–573 http://dx.doi.org/10.1097/00006231-199706000-00012CrossrefGoogle Scholar

  • [26] Sarullo FM, Ventimiglia C, Taormina A et al. Safety and feasibility of atropine added in patients with sub-maximal heart rate during exercise myocardial perfusion SPECT, Int J Cardiovasc Imaging 2007; 23: 511–518 http://dx.doi.org/10.1007/s10554-006-9169-5CrossrefGoogle Scholar

  • [27] David D, Lang RM, Borow KM. Clinical utility of exercise, pacing, and pharmacologic stress testing for the noninvasive determination of myocardial contractility and reserve, Am Heart J 1988; 116: 235–247 http://dx.doi.org/10.1016/0002-8703(88)90284-0CrossrefGoogle Scholar

  • [28] Katzung BG. Basic and clinical pharmacology, New York: Lange Medical, McGraw-Hill; 2001 p. 115 Google Scholar

  • [29] Variola A, Albiero R, Dander B, Buonanno C. Exercise testing with atropine [in Italian], G Ital Cardiol 1997; 27: 255–262 Google Scholar

  • [30] Munagala VK, Guduguntla V, Kasravi B, Cummings G, Gardin JM. Use of atropine in patients with chronotropic incompetence and poor exercise capacity during treadmill stress testing, Am Heart J 2003; 145: 1046–1050 http://dx.doi.org/10.1016/S0002-8703(02)94703-4CrossrefGoogle Scholar

About the article

Published Online: 2012-02-03

Published in Print: 2012-04-01


Citation Information: Open Medicine, Volume 7, Issue 2, Pages 262–268, ISSN (Online) 2391-5463, DOI: https://doi.org/10.2478/s11536-012-0001-4.

Export Citation

© 2011 Versita Warsaw. This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License. BY-NC-ND 3.0

Comments (0)

Please log in or register to comment.
Log in